NERV logo

Minerva Neurosciences, Inc. (NERV)

Profile

Full Name

Minerva Neurosciences, Inc.

Ticker

NASDAQ: NERV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 1, 2014

Indexes

Not included

Website

https://www.minervaneurosciences.com

Employees

8

Key Details

Price

$2.42(+5.09%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

$0.19(+104.12% YoY)

PE ratio

1.63

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.42
    NERV price is $2.42

    30-Day Relative Volume

    0.43
    NERV 30-day relative volume is 0.43

    Price Performance

    Price Most recent change

    +5.09%
    NERV price was up +5.09% on Aug 21, 2025

    Price YTD change

    +8.69%
    NERV price is up +8.69% since January 1st

    Price 1-year change

    -6.76%
    NERV price is down -6.76% year-on-year

    Price 3-year change

    -47.39%
    NERV price is down -47.39% over the past 3 years

    Price Range

    Price All-time high

    $126.72
    NERV price is currently -98.09% below its historical high of $126.72

    Price 3-year low

    $1.15
    NERV price is currently +110.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $16.89M
    NERV market capitalization is $16.89 million

    Market cap 3-year change

    -31.1%
    NERV market capitalization is down -31.1% over the past 3 years

    Market cap All-time high

    $576.52M
    NERV market capitalization is currently -97.07% below its historical high of $576.52 million

    Market cap sector rank

    21.91%
    NERV market capitalization is higher than 21.91% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    NERV shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +30.96%
    NERV shares outstanding is up +30.96% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.39
    NERV beta is 0.39

    200-day SMA

    $1.91
    NERV price is currently +26.23% above its 200-day simple moving average

    50-day SMA

    $1.88
    NERV price is currently +28.30% above its 50-day simple moving average

    RSI

    69.43
    NERV 14-day relative strength index is 69.43

    Volume

    0.43
    NERV 30-day relative volume is 0.43

    ATR

    $0.19
    NERV average true range is $0.19

    10-day Historical Volatility

    138.05%
    NERV 10-day historical volatility is 138.05%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    NERV annual revenue is $0.00

    Revenue Analysts estimate

    -
    NERV annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    NERV annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.61%
    NERV annual revenue is higher than 28.61% of companies in Healthcare sector

    EPS

    EPS

    $0.19
    NERV annual earnings per share is $0.19

    EPS Analysts estimate

    -$2.68
    NERV annual earnings per share is currently -107.09% lower than the consensus analysts' forecast

    EPS 1-year change

    +104.12%
    NERV annual earnings per share is up +104.12% year-on-year

    EPS Sector rank

    85.05%
    NERV annual earnings per share is higher than 85.05% of companies in Healthcare sector

    Profit

    Gross profit

    -$22.50K
    NERV annual gross profit is -$22.50 thousand

    Gross margin

    -
    NERV annual gross profit margin value is unknown

    Operating profit

    -$21.85M
    NERV annual operating income is -$21.85 million

    Operating margin

    -
    NERV annual operating profit margin value is unknown

    Net income

    $1.44M
    NERV annual net profit is $1.44 million

    Net margin

    -
    NERV annual net profit margin value is unknown

    Expenses

    Total expenses

    -$1.44M
    NERV annual total expenses is -$1.44 million

    Operating expenses

    $21.83M
    NERV annual total operating expenses is $21.83 million

    Cost of goods sold

    $22.50K
    NERV annual cost of goods sold is $22.50 thousand

    Selling, general & administrative expenses

    $0.00
    NERV annual SGA is $0.00

    Depreciation and amortization

    $22.50K
    NERV annual depreciation & amortization is $22.50 thousand

    Interest expense

    $0.00
    NERV annual interest expense is $0.00

    Income tax

    $0.00
    NERV annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$21.85M
    NERV annual earnings before interest & taxes is -$21.85 million

    EBITDA

    -$21.83M
    NERV annual EBITDA is -$21.83 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $37.14M
    NERV annual total assets is $37.14 million

    Non current assets

    $14.87M
    NERV annual long term assets is $14.87 million

    Current assets

    $22.27M
    NERV annual total current assets is $22.27 million

    Cash and cash equivalents

    $21.46M
    NERV annual cash & cash equivalents is $21.46 million

    Accounts receivable

    -
    NERV annual accounts receivable value is unknown

    Inventory

    $0.00
    NERV annual inventory is $0.00

    Liabilities

    Total liabilities

    $62.84M
    NERV annual total liabilities is $62.84 million

    Long term liabilities

    $60.00M
    NERV annual total long term liabilities is $60.00 million

    Current liabilities

    $2.84M
    NERV annual total current liabilities is $2.84 million

    Accounts payable

    $1.61M
    NERV annual accounts payable is $1.61 million

    Debt

    Total debt

    $60.00M
    NERV annual total debt is $60.00 million

    Total debt 1-year change

    -26.84%
    NERV annual total debt is down -26.84% year-on-year

    Long term debt

    $60.00M
    NERV annual long term debt is $60.00 million

    Short term debt

    $0.00
    NERV annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    -$25.69M
    NERV annual stockholders equity is -$25.69 million

    Book value

    -$25.69M
    NERV annual book value is -$25.69 million

    Retained earnings

    -$395.38M
    NERV annual retained earnings is -$395.38 million

    Working capital

    $19.43M
    NERV annual working capital is $19.43 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$19.55M
    NERV annual cash flow from operations is -$19.55 million

    Cash from operations 1-year change

    -32.24%
    NERV annual cash flow from operations is down -32.24% year-on-year

    Cash from investing

    $0.00
    NERV annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    0%
    NERV annual cash flow from investing activities has remained unchanged year-on-year

    Cash from financing

    $0.00
    NERV annual cash flow from financing activities is $0.00

    Cash from financing 1-year change

    -100%
    NERV annual cash flow from financing activities is down -100% year-on-year

    CAPEX

    CAPEX

    $0.00
    NERV annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    NERV annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$19.55M
    NERV annual free cash flow is -$19.55 million

    Free cash flow 1-year change

    -32.24%
    NERV annual free cash flow is down -32.24% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    NERV annual gross profit margin value is unknown

    Operating margin

    -
    NERV annual operating profit margin value is unknown

    Net margin

    -
    NERV annual net profit margin value is unknown

    ROA & ROE

    ROA

    3.06%
    NERV annual return on assets is 3.06%

    ROE

    -5.60%
    NERV annual return on equity is -5.60%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    1.63
    NERV price to earnings ratio is 1.63

    PE ratio Sector rank

    5.19%
    NERV price to earnings ratio is higher than 5.19% of companies in Healthcare sector

    PB Ratio

    PB ratio

    -0.53
    NERV price to book ratio is -0.53

    PB ratio Sector rank

    11.57%
    NERV price to book ratio is higher than 11.57% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    NERV price to sales ratio value is unknown

    PS ratio Sector rank

    -
    NERV price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $61.54M
    NERV enterprise value is $61.54 million

    Enterprise value Sector rank

    42.55%
    NERV enterprise value is higher than 42.55% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.81
    NERV EV/EBITDA is -3.81

    EV/EBITDA Sector rank

    25.56%
    NERV EV/EBITDA is higher than 25.56% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.85
    NERV annual current ratio is 7.85

    Quick ratio

    7.85
    NERV annual quick ratio is 7.85

    Leverage

    Debt to equity

    -2.34
    NERV annual debt to equity ratio is -2.34

    Interest coverage ratio

    -
    NERV annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    NERV piotroski f-score value is unknown

    Altman Z-Score

    -16.05
    NERV altman z-score is -16.05

    Analyst ratings

    Recent major analysts updates

    Feb 26, 25 HC Wainwright & Co.
    Neutral
    Nov 6, 24 HC Wainwright & Co.
    Neutral
    Aug 7, 24 HC Wainwright & Co.
    Neutral
    May 2, 24 HC Wainwright & Co.
    Neutral
    Feb 27, 24 HC Wainwright & Co.
    Neutral
    Aug 2, 23 HC Wainwright & Co.
    Neutral
    May 16, 23 HC Wainwright & Co.
    Neutral
    May 2, 23 HC Wainwright & Co.
    Neutral
    Mar 9, 23 HC Wainwright & Co.
    Neutral
    Nov 10, 22 HC Wainwright & Co.
    Neutral

    Institutional Ownership

    Screeners with NERV included

    US stocks
    Best performing stocks last month
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Minerva Neurosciences, Inc.?
    • Does Minerva Neurosciences, Inc. pay dividends?
    • What sector is Minerva Neurosciences, Inc. in?
    • What industry is Minerva Neurosciences, Inc. in?
    • What country is Minerva Neurosciences, Inc. based in?
    • When did Minerva Neurosciences, Inc. go public?
    • Is Minerva Neurosciences, Inc. in the S&P 500?
    • Is Minerva Neurosciences, Inc. in the NASDAQ 100?
    • Is Minerva Neurosciences, Inc. in the Dow Jones?
    • When was Minerva Neurosciences, Inc.'s last earnings report?
    • When does Minerva Neurosciences, Inc. report earnings?

    What is the ticker symbol for Minerva Neurosciences, Inc.?

    The ticker symbol for Minerva Neurosciences, Inc. is NASDAQ:NERV

    Does Minerva Neurosciences, Inc. pay dividends?

    No, Minerva Neurosciences, Inc. does not pay dividends

    What sector is Minerva Neurosciences, Inc. in?

    Minerva Neurosciences, Inc. is in the Healthcare sector

    What industry is Minerva Neurosciences, Inc. in?

    Minerva Neurosciences, Inc. is in the Biotechnology industry

    What country is Minerva Neurosciences, Inc. based in?

    Minerva Neurosciences, Inc. is headquartered in United States

    When did Minerva Neurosciences, Inc. go public?

    Minerva Neurosciences, Inc.'s initial public offering (IPO) was on July 1, 2014

    Is Minerva Neurosciences, Inc. in the S&P 500?

    No, Minerva Neurosciences, Inc. is not included in the S&P 500 index

    Is Minerva Neurosciences, Inc. in the NASDAQ 100?

    No, Minerva Neurosciences, Inc. is not included in the NASDAQ 100 index

    Is Minerva Neurosciences, Inc. in the Dow Jones?

    No, Minerva Neurosciences, Inc. is not included in the Dow Jones index

    When was Minerva Neurosciences, Inc.'s last earnings report?

    Minerva Neurosciences, Inc.'s most recent earnings report was on August 5, 2025

    When does Minerva Neurosciences, Inc. report earnings?

    The date for Minerva Neurosciences, Inc.'s next earnings report has not been announced yet
    On this page